February 2012
European Commission approves Avastin® as ovarian cancer treatment
- Wed, 02/15/2012 - 10:31am
- Comments
The European Commission made the decision to approve Avastin as a treatment for women diagnosed with advanced
Johnson & Johnson sued for vaginal mesh complications
- Wed, 02/15/2012 - 10:26am
- Comments
Pharmaceutical giant, Johnson & Johnson, now faces thousands of transvaginal mesh lawsuits by women who c
How the risk for a femur fracture injury can be lowered
- Tue, 02/14/2012 - 10:37am
- Comments
According to a new study the risk for suffering a second femur fracture injury may be lowered when the use of bisphosph
Transvaginal mesh implants causes adverse effects
- Tue, 02/14/2012 - 10:20am
- Comments
According to complaints received by the Food and Drug Administration (FDA), transvaginal mesh has been causin
Pradaxa and Xarelto linked to internal bleeding
- Mon, 02/13/2012 - 11:04am
- Comments
Zimmer NexGen knee replacement causes lawsuit
- Mon, 02/13/2012 - 11:02am
- Comments
Zimmer NexGen knee replacements have been linked to
Xigris® recalled from the market
- Fri, 02/10/2012 - 1:41pm
- Comments
Xigris® (drotrecogin alfa), a synthetic version of protein C, which is a natural protein found in the body, was introduced in 2001.
Increased concerns associated with Pradaxa® use
- Fri, 02/10/2012 - 10:45am
- Comments
The Food and Drug Administration approved Pradaxa use in October 2010.
Pradaxa® and Xarelto® linked to internal bleeding
- Thu, 02/09/2012 - 12:58pm
- Comments
Pradaxa linked to adverse side effects
- Thu, 02/09/2012 - 10:39am
- Comments
Pradaxa is a blood thinning medication prescribed to prevent blood clots and str